# Grace Therapeutics, Inc.: Form 8-K, filed Aug 9, 2024

- Company: [Grace Therapeutics, Inc.](/companies/grce.md) (CIK 1444192)
- Form: 8-K
- Filed: 2024-08-09
- Accepted by EDGAR: Aug 9, 2024, 08:00 ET
- Period: 2024-08-09
- Accession: 0000950170-24-094359
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1444192/000095017024094359/acst-20240809.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1444192/000095017024094359/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1444192/000095017024094359/acst-20240809.htm

Filed Aug 9, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-094359. Last ingested by Listed: Oct 26, 2026, 18:07 ET. No prices; not investment advice.